levodopa/carbidopa/entacapone orion
orion corporation - levodopa, carbidopa, entacapone - parkinsonova choroba - nervový systém - levodopa/carbidopa/entacapone orion je indikovaný na liečbu dospelých pacientov s parkinsonovou chorobou a motorickými fluktuáciami na konci účinku dávky nie stabilizovaní levodopy / dopadekarboxylázy (ddc)-liečby inhibítormi sglt2.
levodopa/carbidopa/entacapone teva 50 mg/12,5 mg/200 mg
teva pharmaceuticals slovakia s.r.o. - levodopa, inhibítor dekarboxylázy a comt inhibítor - 27 - antiparkinsonica
levodopa/carbidopa/entacapone teva 75 mg/18,75 mg/200 mg
teva pharmaceuticals slovakia s.r.o. - levodopa, inhibítor dekarboxylázy a comt inhibítor - 27 - antiparkinsonica
levodopa/carbidopa/entacapone teva 100 mg/25 mg/200 mg
teva pharmaceuticals slovakia s.r.o. - levodopa, inhibítor dekarboxylázy a comt inhibítor - 27 - antiparkinsonica
levodopa/carbidopa/entacapone teva 125 mg/31,25 mg/200 mg
teva pharmaceuticals slovakia s.r.o. - levodopa, inhibítor dekarboxylázy a comt inhibítor - 27 - antiparkinsonica
levodopa/carbidopa/entacapone teva 175 mg/43,75 mg/200 mg
teva pharmaceuticals slovakia s.r.o. - levodopa, inhibítor dekarboxylázy a comt inhibítor - 27 - antiparkinsonica
levodopa/carbidopa/entacapone teva 200 mg/50 mg/200 mg
teva pharmaceuticals slovakia s.r.o. - levodopa, inhibítor dekarboxylázy a comt inhibítor - 27 - antiparkinsonica
levodopa/carbidopa/entacapone stada 50 mg/12,5 mg/200 mg
stada arzneimittel ag, nemecko - levodopa, inhibítor dekarboxylázy a comt inhibítor - 27 - antiparkinsonica
levodopa/carbidopa/entacapone stada 200 mg/50 mg/200 mg
stada arzneimittel ag, nemecko - levodopa, inhibítor dekarboxylázy a comt inhibítor - 27 - antiparkinsonica
levodopa/carbidopa/entacapone stada 175 mg/43,75 mg/200 mg
stada arzneimittel ag, nemecko - levodopa, inhibítor dekarboxylázy a comt inhibítor - 27 - antiparkinsonica